Quantbot Technologies LP Coherus Bio Sciences, Inc. Transaction History

Quantbot Technologies LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$2.02 - $3.14 $40,198 - $62,486	19,900 New	19,900 $47,000
Q1 2023 May 12, 2023	BUY	$5.89 - $10.52 $67,146 - $119,928	11,400 New	11,400 $77,000
Q4 2021 Feb 11, 2022	SELL	$15.81 - $18.99 $8,663 - $10,406	-548 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$12.68 - $17.79 $1,661 - $2,330	131 Added 31.41%	548 $8,000
Q2 2021 Aug 12, 2021	BUY	$12.95 - $15.41 $5,400 - $6,425	417 New	417 $5,000
Q4 2020 Feb 12, 2021	SELL	$16.56 - $18.94 $28,151 - $32,198	-1,700 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.41 - $19.89 $29,597 - $33,813	1,700 New	1,700 $31,000
Q1 2020 May 13, 2020	SELL	$11.67 - $22.53 $1,668 - $3,221	-143 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$16.33 - $21.37 $2,498 - $3,269	-153 Reduced 51.69%	143 $2,000
Q3 2019 Nov 12, 2019	BUY	$16.3 - $23.37 $4,824 - $6,917	296 New	296 $5,000
Q3 2018 Nov 13, 2018	SELL	$14.45 - $20.25 $74,590 - $104,530	-5,162 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$10.25 - $17.45 $30,268 - $51,529	2,953 Added 133.68%	5,162 $72,000
Q1 2018 May 11, 2018	BUY	$9.1 - $13.7 $20,101 - $30,263	2,209 New	2,209 $24,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.